Peptides

TET 830 modified/T-helper epitope from tetanus toxoid - 1 mg

$167.00
Check your price
  • Cat.Number : AS-60622
  • Availability :
    In stock

Quantity

TET 830 modified/T-helper epitope from tetanus toxoid is a universal human tetanus toxin T cell epitope. It induces T-cell activation and is used as a helper peptide in vaccinations.

Specifications

Chemistry
Sequence one letter code
  • AQYIKANSKFIGITEL
Sequence three letter code
  • H-Ala-Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Leu-OH
Molecular Formula
  • C83H134N20O24
Molecular Mass/ Weight
  • 1796.2
Modification
Conjugation
  • Unconjugated
Quantity & Purity
Purity
  • Peak Area by HPLC ≥95%
Storage & stability
Form
  • Lyophilized
Storage Conditions
  • - 20 °C
Activity
Biomarker Target
Research Area
Sub-category Research Area
Usage
  • Research use
Source
Source / Species
  • Clostridium tetani

You may also be interested in the following product(s)

IMG-EN-AS-62604-01.jpg

Caloxin 2A1 - 1 mg

Cat.Number : AS-62604
$119.00 Excl. Tax
IMG-EN-AS-60763-01.jpg

Iberiotoxin (IbTX) - 0.1 mg

Cat.Number : AS-60763
$172.00 Excl. Tax
IMG-EN-AS-22926-01.jpg

ω-Conotoxin GVIA

Cat.Number : AS-22926
$261.00 Excl. Tax

References

Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

J Clin Oncol . 2003 Nov 01 ; 21(21) 4016 | DOI : 10.1200/JCO.2003.10.005

  • C. Slingluff
  • et al

Delineation of several DR-restricted tetanus toxin T cell epitopes.

J Immunol . 1989 Jan 15 ; 142(2) 394

  • S. Demotz
  • et al

Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination.

J. Immunol. . 1992 Jul 15 ; 149(2) 717

  • D. Valmori
  • et al

Phase I Trial of a Melanoma Vaccine with gp100280–288 Peptide and Tetanus Helper Peptide in Adjuvant

Clin Cancer Res . 2001 Oct 01 ; 7(10) 3012 | DOI : https://clincancerres.aacrjournals.org/content/7/10/3012.long

  • C. Slingluff
  • et al